Rat Allergy Shots: Rat n 1, the 42-Fold LAA Risk, and Pet-Rat Allergy
Rat allergy has the most striking occupational risk amplification in LAA — Hollander et al. (1997) documented a 42-fold higher prevalence in heavily exposed atopic workers. Rat n 1 sensitizes 73-90% of rat-allergic patients and shares 60-80% homology with mouse Mus m 1. No FDA-standardized rat extract exists.
Rat Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to rat — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of rat allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of rat immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of rat extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for rat allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing rat extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription rat immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat rat allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Rat?
The biology, taxonomy, and clinical fingerprint of Rat — the foundation of how SCIT targets it.
Rat n 1 isoform Rat n 1B is androgen-dependent (hepatic origin) — male rats produce substantially more than females. Most rodent-sensitized workers show co-sensitization to both Rat n 1 and Mus m 1 via cross-reactive rather than independent sensitization (Jeal et al., Allergy 2009).
- Scientific name
- Rattus norvegicus
- Family
- MuridaeMouse and rat family
- Type
- Laboratory animal and pet-rat allergen
- Native to
- Central Asia; commensal global distribution as a human commensal species
- Allergen proteins
- Rat n 1 (major) — alpha2u-globulin lipocalin; exists as two isoforms: Rat n 1A (~20 kDa, salivary gland origin) and Rat n 1B (~17 kDa, hepatic origin, androgen-dependent)73-90% of rat-allergic patients have IgE to Rat n 1 (Gordon et al., Clin Exp Allergy 1996)Rat n 1 found in urine, saliva, and pelt; urine is the dominant allergen sourceMouse serum albumin analog in rat — ~67 kDa; cross-reactive with mammalian albumin family
- Particle size
- Rat n 1 in urine aerosolizes as submicron particles; cage changes generate highest airborne concentrations
- Avoidance difficulty
- Moderate
How Rat Allergy Presents
Symptoms by body system — useful for distinguishing Rat sensitivity from overlapping allergies and infections.
Respiratory
- Rhinitis as the first LAA symptom — mean onset 7 months after initial rat exposure
- Asthma progression in 4-22% of symptomatic workers with continued occupational exposure
- Nasal congestion and sneezing triggered by urine aerosolization during cage cleaning
- Occupational asthma causing permanent airways disease in untreated, continuously exposed sensitized workers
- Pet-rat owners: perennial rhinitis from small home colonies, especially when cage is in the bedroom
Ocular
- Conjunctivitis during and after rat handling in laboratory workers
- Eye itching and lacrimation with cage-cleaning tasks — peak urine aerosolization
- Periorbital swelling in highly sensitized individuals
- Ocular symptoms typically accompanying nasal reactions in sensitized workers
Dermal
- Contact urticaria at rat bite or scratch sites in laboratory workers
- Hive formation after direct rat contact in sensitized handlers
- Atopic dermatitis flare in pet-rat owners with regular handling
- Skin symptoms less prominent than respiratory symptoms in most LAA presentations
Systemic
- Occupational disability with career disruption in laboratory workers who develop severe occupational asthma
- Fatigue from chronic perennial rhinitis in pet-rat owners or workers with daily exposure
- Rarely, anaphylaxis in highly sensitized individuals with concentrated acute allergen exposure
- Sleep disruption and reduced quality of life in affected laboratory workers
Rat is one of the cleaner laboratory animal allergy stories — atopic worker, year of exposure, nasal symptoms, then sometimes asthma. The pet-rat community is a different population: usually one or two animals in the home, and they're often a primary affection object. We have very limited SCIT-specific RCT data; what we have is occupational worker cohorts and inferred efficacy from the LAA framework.
Where Rat Triggers Year-Round
Rat is a perennial trigger — exposure is constant for sensitized patients. Geographic intensity still varies by climate.
12-Month Intensity
Year-roundPerennial year-round — no seasonal variation for laboratory or pet rat exposure.· Year-round for both laboratory and household pet-rat exposure.
US Exposure Map
20 high-intensity statesWhat Rat Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Rat n 1 is the center of a rodent lipocalin network — its 60-80% homology with mouse Mus m 1 makes co-sensitization the rule rather than the exception, and additional lipocalin cross-reactivity extends to horse, cat, and dog.
Rat n 1 ↔ Mus m 1: 60-80% sequence homology — the closest cross-reactive pair in animal allergy; most rodent-sensitized workers are co-sensitized (Jeal et al., Allergy 2009)
Rodent lipocalin family cross-reactivity expected by Muridae phylogenetic homology — not directly characterized for gerbil
Rat n 1 ↔ Cav p 1 lipocalin family — common co-sensitization in multi-species laboratory animal workers
Is SCIT Right for Your Rat Allergy?
Answer five questions to assess your rat allergy situation and whether SCIT is appropriate for your context.
How severe are your rat allergy symptoms?
The Rat SCIT Protocol
Rat SCIT uses non-FDA-standardized epithelial or urine-based extract. Because Rat n 1 ↔ Mus m 1 cross-reactivity is 60-80%, the allergist should confirm via component testing whether rat or mouse is the primary sensitizer before choosing the extract.
Standard inhalant SCIT build-up from diluted starting concentrations. NIOSH 97-116 engineering controls (IVCs, HEPA, directional airflow, N95 during cage changes, corncob bedding) should be in place concurrently. Because rat and mouse Rat n 1/Mus m 1 are cross-reactive, single-species rat SCIT may inadvertently provide partial mouse coverage in co-exposed workers. 30-minute post-injection observation is mandatory.
Maintenance injections continue alongside ongoing occupational controls. Regular lung function monitoring for workers with occupational asthma. For pet-rat owners, environmental control measures should be maintained throughout the course.
Workers who transition to non-animal-handling laboratory roles during the course may achieve lasting remission. Pet-rat owners whose pets have died and who do not acquire new rats may also achieve lasting improvement after completing the course.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Rat SCIT
No double-blind placebo-controlled RCT for rat SCIT specifically has been published. Evidence is derived from LAA occupational cohort data, most notably Hollander et al.'s 42-fold prevalence amplification finding.
- Prevalence amplification in atopic heavily exposed workers42%Hollander A et al., 1997; 42-fold higher prevalence of symptomatic rat allergy in heavily exposed atopic individuals
- Rat n 1 sensitization rate in rat-allergic patients82%Gordon S et al., Clin Exp Allergy 1996; 73-90% of rat-allergic patients have Rat n 1 IgE
No DBPC-RCT specifically studying rat SCIT is available. Clinical use is extrapolated from the general AAAAI/ACAAI Practice Parameter framework (Cox et al., JACI 2011) and from LAA occupational cohort data demonstrating that atopic laboratory workers with early rhinitis progress to occupational asthma with continued exposure, providing rationale for immune-modifying intervention. The 42-fold prevalence amplification in heavily exposed atopic workers (Hollander 1997) is the most striking evidence point for the magnitude of occupational risk this allergen presents.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Rat SCIT Side Effects
Rat SCIT side effects follow the general inhalant SCIT profile when non-standardized epithelial extract is used.
Local reactions
4 documentedSystemic reactions
4 documentedTraditionally SCIT was given only in a clinic, but for eligible maintenance patients Curex makes safe at-home self-administration possible: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist. Workers with occupational asthma require spirometry monitoring and stable lung function confirmation before each injection, and reactions typically begin within ~30 minutes, so a brief post-injection self-observation is advised.
SCIT vs Alternatives for Rat
For laboratory workers, NIOSH 97-116 engineering controls are first-line with SCIT as a secondary option. For pet-rat owners, rehoming or environmental control should be considered before immunotherapy.
| Criterion | SCITBest | SLIT | Engineering controls (occupational) | Pet rehoming |
|---|---|---|---|---|
| Effectiveness | Limited — no RCT; LAA cohort rationale | Off-label; less evidence than occupational SCIT | Significant allergen reduction with full implementation | Complete — definitive if strict |
| 5-yr cost | $3,500-$10,000 | $129/month | Variable | $0 |
| Duration | 3-5 years | 3-5 years | Permanent | Permanent |
| Convenience | Self-administered weekly at home with Curex (build-up) | Daily drops at home | Operational changes | Emotionally difficult but effective |
| Safety | Very safe; Curex confirms prescribed epinephrine on hand and supervises your first dose and every dose change live over Zoom | Very safe; no clinic required | No medical side effects | No side effects |
| Lasting effect | Some sustained benefit post-course | Ongoing benefit while continuing | Permanent if maintained | Permanent |
SCITBest
SLIT
Engineering controls (occupational)
Pet rehoming
For laboratory workers with confirmed Rat n 1 sensitization who cannot change professions, SCIT alongside NIOSH 97-116 controls offers the best available immune-modifying approach. Curex delivers that immunotherapy as an at-home allergy shot at $129/month for shift-working laboratory technicians and rural pet-rat owners whose schedules or geographic location make weekly clinic appointments impractical — a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand.
What Rat SCIT Actually Costs
Most major US health insurers cover occupational allergen immunotherapy under standard allergy benefits with documented IgE sensitization and medical necessity. Coverage for pet-rat allergy SCIT may be more variable. A board-certified allergist's documentation of confirmed Rat n 1 sensitization and failed environmental management strengthens coverage applications. Out-of-pocket costs depend on deductible and co-insurance. Curex at-home IgE testing identifies specific rat sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your rat allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Rat SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Hollander et al. (1997) documented that heavily exposed atopic laboratory workers had a 42-fold higher prevalence of symptomatic rat allergy compared to unexposed controls. This is one of the strongest occupational risk amplification findings in the entire laboratory animal allergy literature. The three key risk amplifiers are: (1) atopy — pre-existing allergic tendency — which confers at least a 3-fold increased sensitization risk even at low allergen exposure (Heederik et al., JACI 1999); (2) exposure intensity — heavy exposure magnifies the risk dramatically; and (3) time — sensitization typically occurs within 12 months and can progress from rhinitis to occupational asthma with continued exposure. This evidence base is the primary rationale for pre-placement atopy screening and regular LAA medical surveillance in animal facilities, as recommended by NIOSH Alert 97-116.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.